John Hussman's TGTX Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 0 shares of TG Therapeutics, Inc. (TGTX) worth $0, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, John Hussman has maintained this position in TGTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2024, adding 105,000 shares. Largest reduction occurred in Q4 2025, reducing 126,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's TG Therapeutics (TGTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TG Therapeutics (TGTX) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -126,000 | Sold Out | 0 | $0.00 |
| Q2 2025 | +73,500 | Add 140.00% | 126,000 | $35.99 |
| Q1 2025 | +10,500 | Add 25.00% | 52,500 | $39.43 |
| Q4 2024 | -63,000 | Reduce 60.00% | 42,000 | $30.10 |
| Q3 2024 | +105,000 | New Buy | 105,000 | $23.39 |
| Q4 2023 | -52,500 | Sold Out | 0 | $0.00 |
| Q3 2023 | +52,500 | New Buy | 52,500 | $8.36 |
John Hussman's TG Therapeutics Investment FAQs
John Hussman first purchased TG Therapeutics, Inc. (TGTX) in Q3 2023, acquiring 52,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held TG Therapeutics, Inc. (TGTX) for 8 quarters since Q3 2023.
John Hussman's largest addition to TG Therapeutics, Inc. (TGTX) was in Q3 2024, adding 105,000 shares worth $2.46 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 0 shares of TG Therapeutics, Inc. (TGTX), valued at approximately $0.
As of the Q4 2025 filing, TG Therapeutics, Inc. (TGTX) represents approximately 0.00% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in TG Therapeutics, Inc. (TGTX) was 126,000 shares, as reported at the end of Q2 2025.